Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TGX-221
i
Other names:
TGX-221
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Enzo, Pfizer, Wuhan University
Drug class:
PI3Kβ inhibitor, Apoptosis inducer
Related drugs:
‹
GSK2636771 (8)
AZD8186 (4)
AZD6482 (2)
CVL237 (0)
GS-9820 (0)
nanoliposomal ceramide (2)
BCN057 (1)
RITA (0)
EPC2407 (0)
iMX-110 (0)
ST-001 nanoFenretinide (0)
SAR650984 SC (0)
Andes-1537 (0)
CB1089 (0)
Utt-B (0)
GSK2636771 (8)
AZD8186 (4)
AZD6482 (2)
CVL237 (0)
GS-9820 (0)
nanoliposomal ceramide (2)
BCN057 (1)
RITA (0)
EPC2407 (0)
iMX-110 (0)
ST-001 nanoFenretinide (0)
SAR650984 SC (0)
Andes-1537 (0)
CB1089 (0)
Utt-B (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PTEN mutation
Endometrial Cancer
PTEN mutation
Endometrial Cancer
TGX-221
Sensitive: D – Preclinical
TGX-221
Sensitive
:
D
TGX-221
Sensitive: D – Preclinical
TGX-221
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login